Multimodality therapy for stage III non-small-cell lung cancer.
Farray D, Mirkovic N, Albain KS.
Farray D, et al.
J Clin Oncol. 2005 May 10;23(14):3257-69. doi: 10.1200/JCO.2005.03.008.
J Clin Oncol. 2005.
PMID: 15886313
Review.
The treatment of stage III non-small-cell lung cancer has evolved over the last two decades, with combined-modality therapy the current standard of care. As a result, intermediate and long-term survival has improved for patients in this common stage category, compared to t …
The treatment of stage III non-small-cell lung cancer has evolved over the last two decades, with combined-modality therapy the current stan …